Monica Borgonovi - Concepedia

Author

Monica Borgonovi

Galapagos (France)

Also Known As

Borgonovi, Monica, M Borgonovi, M. Borgonovi, MONICA BORGONOVI, Monica Borgonovi

Publications

601

Citations

H-Index

Concepts

All Affiliations

Galapagos (France)Galapagos (Belgium)Pliva (Croatia)

About

Monica Borgonovi is an author at Galapagos (France) specializing in medicine, pharmacology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	95
2	Health Sciences	2	2	25
3	Natural Sciences	1	1	54
4	Biochemistry	1	1	54
5	Metabolism	1	1	54

Monica Borgonovi

Publications

550

Citations

H-Index

Page 1

	Year	Citations
In-vitro and in-vivo antibacterial activity of BI 397, a new semi-synthetic glycopeptide antibiotic Gianpaolo Candiani, Monica Abbondi, Monica Borgonovi, Journal of Antimicrobial Chemotherapy	1999	150
Activities of Ceftazidime and Avibactam against β-Lactamase-Producing Enterobacteriaceae in a Hollow-Fiber Pharmacodynamic Model Ken Coleman, Premavathy Levasseur, Anne-Marie Girard, Antimicrobial Agents and Chemotherapy	2014	85
Discovery of<i>N</i>-(3-Carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4<i>H</i>-thieno[2,3-<i>c</i>]pyran-2-yl)-l<i>H</i>-pyrazole-5-carboxamide (GLPG1837), a Novel Potentiator Which Can Open Class III Mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels to a High Extent Steven E. Van der Plas, Hans Kelgtermans, Tom De Munck, Journal of Medicinal Chemistry	2017	58
Teicoplanin metabolism in humans A. Bernareggi, Angelo Borghi, Monica Borgonovi, Antimicrobial Agents and Chemotherapy Medicinal ChemistryPharmaceutical ChemistryBiochemistryMedicineNatural Sciences	1992	54
Discovery of the S1P2 Antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a Preclinical Candidate for the Treatment of Idiopathic Pulmonary Fibrosis Oscar Mammoliti, Adeline Palisse, Caroline Joannesse, Journal of Medicinal Chemistry	2021	30
Mulundocandin, an Echinocandin-like Lipopeptide Antifungal Agent: Biological Activities In Vitro. Stephen Hawser, Monica Borgonovi, Astrid Markus, The Journal of Antibiotics	1999	29
Evaluation of a novel CFTR potentiator in COPD ferrets with acquired CFTR dysfunction Niroop Kaza, Vivian Lin, D. Stanford, European Respiratory Journal	2021	29
Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312 Taouès Temal-Laib, Christophe Peixoto, Nicolas Desroy, Journal of Medicinal Chemistry	2023	20
Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases Christophe Peixoto, Agnès Joncour, Taouès Temal-Laib, Journal of Medicinal Chemistry	2024	20
Discovery and Optimization of Orally Bioavailable Phthalazone and Cinnolone Carboxylic Acid Derivatives as S1P2 Antagonists against Fibrotic Diseases Oscar Mammoliti, Koen Jansen, Sandy El Bkassiny, Journal of Medicinal Chemistry	2021	19

Page 1